The platform features Healthgrades, a tool intended to connect Alzheimer's patients to experienced local clinicians.

The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the risk of serious brain ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 ...

Shape Memory Medical Inc., innovator of shape memory polymer for endovascular applications, today announced that its proprietary platform has been used to treat its 3,000th patient—a significant ...

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...

Northwest Clinical Research Center specializes in clinical trials for new medications designed to slow or prevent diseases ...

Ask most health professionals what you can do to prevent or delay dementia, and you will likely be told to maintain a healthy diet, exercise regularly, control your blood pressure, blood sugar and ...

The company said its goal is to reduce wait times for patients seeking access to specialists, creating more opportunities for ...